A novel gene therapy platform for the treatment of type 2 diabetes and obesity.

Lourie J, Goraltchouk A, Hollander JM, Berger NJ, Rosen HG, Fujishiro AA, Luppino F, Seregin A, Rhym L, Zou K

Open source

DOI
10.1016/j.omtn.2025.102739
Published
2025 Dec 9
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2025.102739,
  title = {A novel gene therapy platform for the treatment of type 2 diabetes and obesity.},
  author = {Lourie J and Goraltchouk A and Hollander JM and Berger NJ and Rosen HG and Fujishiro AA and Luppino F and Seregin A and Rhym L and Zou K},
  year = {2025},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2025.102739},
  url = {https://doi.org/10.1016/j.omtn.2025.102739}
}

RIS

TY  - JOUR
TI  - A novel gene therapy platform for the treatment of type 2 diabetes and obesity.
AU  - Lourie J
AU  - Goraltchouk A
AU  - Hollander JM
AU  - Berger NJ
AU  - Rosen HG
AU  - Fujishiro AA
AU  - Luppino F
AU  - Seregin A
AU  - Rhym L
AU  - Zou K
PY  - 2025
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2025.102739
UR  - https://doi.org/10.1016/j.omtn.2025.102739
ER  - 

APA

J, L., A, G., JM, H., NJ, B., HG, R., AA, F., F, L., A, S., L, R., & K, Z. (2025). A novel gene therapy platform for the treatment of type 2 diabetes and obesity.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2025.102739

Source records